Sarcoidosis is an enigmatic and chronic systemic disease that often targets the respiratory system. Despite advances in medical research, sarcoidosis care continues to face challenges due to its unpredictable nature and patient-specific variability. Consistent with the gradual shift to personalized medicine and digital health solutions, a comprehensive home monitoring program designed specifically for sarcoidosis patients has shown promising results for its feasibility and user satisfaction. This article delves into these findings, highlighting the implications for future patient-centric care models in sarcoidosis management.

The Home Monitoring Breakthrough

In a study published in the Journal of Personalized Medicine (DOI: 10.3390/jpm9020023), researchers from Erasmus Medical Center, Rotterdam, delineate a new paradigm in the administration of sarcoidosis care. The study introduces “Sarconline” – a secure home monitoring platform that integrates daily wireless spirometry, an online patient-reported outcomes portal, an activity tracker, along with a comprehensive information library, and an eContact option for prompt medical assistance.

Comprehensive Study Insights

The feasibility study enrolled ten outpatient individuals diagnosed with pulmonary sarcoidosis to test the “Sarconline” program. Over one month, participants engaged in daily spirometry readings and activity tracking, as well as the baseline and subsequent completion of patient-reported outcomes. Their experiences with the program were then assessed through phone interviews.

Positive Patient Feedback

The results unveiled an overwhelmingly positive response. 90% of study participants identified the application as user-friendly, none felt burdened by daily health measurements, and unanimously, individuals expressed interest in continuing the program post-study. Remarkably, adherence to daily home spirometry and the activity tracker hit average rates of 94.6% and 91.3%, respectively.

Clinical Significance and Future Directions

With the feasibility of a comprehensive home monitoring program effectively established, its significance lies in the empowerment of patients in managing their condition closely and the provision of real-time data for healthcare providers. This model opens avenues for real-time disease management and fosters an environment conducive to personalized treatment strategies.


1. Moor, C. C., Gür-Demirel, Y., Wijsenbeek, M. S. et al. Feasibility of a Comprehensive Home Monitoring Program for Sarcoidosis. Journal of Personalized Medicine 2020, 9(2), 23; DOI: 10.3390/jpm9020023.

2. Spagnolo, P., Oldham, J.M., Jones, M.G., Lee, J.S. Personalized Medicine in Interstitial Lung Diseases. Curr. Opin. Pulm. Med. 2017;23:231–236.

3. Steven, Kohn M. Wearable Devices and Personalized Healthcare. Trends Cardiovasc. Med. 2018;28:151–152.

4. Wicks, P., Stamford, J., Grootenhuis, M.A., Haverman, L., Ahmed, S. Innovations in e-health. Qual. Life Res. 2014;23:195–203.

5. Velardo, C., Shah, S.A., Gibson, O., Clifford, G., Heneghan, C., Rutter, H., Farmer, A., Tarassenko, L. Digital Health System for Personalised COPD Long-term Management. BMC Med. Inform. Decis. Mak. 2017;17:19.


1. Sarcoidosis home monitoring
2. Sarconline platform
3. Personalized sarcoidosis treatment
4. Digital health solutions for sarcoidosis
5. Patient experiences with sarcoidosis technology


In conclusion, the advent of a customizable home monitoring program such as “Sarconline” provides an innovative and patient-centered approach to sarcoidosis care. Embracing these digital health tools and their integration into clinical practice can not only bolster the quality of life for individuals with sarcoidosis but can also catalyze the evolution of treatment regimes toward more personalized, efficient, and responsive healthcare delivery.

It is imperative that stakeholders in the healthcare arena, from clinicians to policy-makers, recognize and support the integration of such technology-driven solutions to ensure optimal disease management and pave the way for extensive research that addresses the dynamic needs of sarcoidosis patients.

This burgeoning field invites further exploration and validation to substantiate its efficacy on a broader scale and solidify its role in routine sarcoidosis care. The findings serve as a testament to the transformative potential of digital health innovations such as “Sarconline,” signalling a hopeful future for individuals grappling with this complex ailment.